Initial Longitudinal Outcomes of Risk-Stratified Men in Their Forties Screened for Prostate Cancer Following Implementation of a Baseline Prostate-Specific Antigen
Authors:
- Zoe D. MichaelZoe D. Michael
- Srinath KotamartiSKSrinath Kotamarti
- Rohith ArcotRARohith Arcot
- Kostantinos MorrisKMKostantinos Morris
- Anand ShahAnand Shah
- John AndersonJAJohn Anderson
- Andrew J. ArmstrongAndrew J. Armstrong
- Rajan T. GuptaRajan T. Gupta
- Steven PatiernoSteven Patierno
- Nadine J. BarrettNadine J. Barrett
- Daniel J. GeorgeDaniel J. George
- Glenn M. PremingerGlenn M. Preminger
Open Access
- 1 January 2022
- journal article
- research article
- Published by Korean Society for Sexual Medicine and Andrology in The World Journal of Men's Health
- Vol. 40 (3) , 631-639
Abstract
Michael ZD, et al. World J Mens Health. 2022 Aug;40:e60. https://doi.org/10.5534/wjmh.220068Keywords
This publication has 25 references indexed in Scilit:
- Primary care providers' perspectives on discontinuing prostate cancer screeningCancer, 2012
- Risk-Based Prostate Cancer ScreeningEuropean Urology, 2012
- Disease-Specific Survival of Men With Prostate Cancer Detected During the Screening Interval: Results of the European Randomized Study of Screening for Prostate Cancer–Rotterdam After 11 Years of Follow-UpEuropean Urology, 2011
- Prostate‐specific antigen 1.5–4.0 ng/mL: a diagnostic challenge and danger zoneBJU International, 2011
- Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50Cancer, 2010
- Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control studyBMJ, 2010
- Initial Prostate Specific Antigen 1.5 ng/ml or Greater in Men 50 Years Old or Younger Predicts Higher Prostate Cancer RiskJournal of Urology, 2010
- Prostate‐specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 yearsBJU International, 2007
- Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years oldUrology, 2006
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterNew England Journal of Medicine, 2004